Involvement of Noxa in mediating cellular ER stress responses to lytic virus infection

Virology

Volumn 417, Issue 2, 2011, Pages 293-303

  Rosebeck, Shaun ^a   Sudini, Kuladeep ^a   Chen, Tiannan ^a   Leaman, Douglas W ^a  

^a UNIVERSITY OF TOLEDO   (United States)

Author keywords

Apoptosis; Bax; Cytopathicity; EMCV; Mcl 1; Salubrinal; VSV

Indexed keywords

CASPASE; DOUBLE STRANDED RNA; MESSENGER RNA; PROTEASOME INHIBITOR; PROTEIN BAX; PROTEIN MCL 1; PROTEIN NOXA;

ANIMAL CELL; APOPTOSIS; ARTICLE; CELL PROTECTION; CONTROLLED STUDY; CYTOPATHOGENIC EFFECT; DISORDERS OF MITOCHONDRIAL FUNCTIONS; ENDOPLASMIC RETICULUM STRESS; ENZYME ACTIVATION; HUMAN; HUMAN CELL; LYTIC VIRUS; LYTIC VIRUS INFECTION; MICROBIAL ACTIVITY; MITOCHONDRIAL MEMBRANE POTENTIAL; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN DEGRADATION; PROTEIN FUNCTION; PROTEIN PROTEIN INTERACTION; REGULATORY MECHANISM; UPREGULATION; VIRUS INFECTION; VIRUS STRAIN; WILD TYPE;

ANIMALS; APOPTOSIS; CYTOPATHOGENIC EFFECT, VIRAL; ENCEPHALOMYOCARDITIS VIRUS; ENDOPLASMIC RETICULUM; GENE EXPRESSION REGULATION; GENETIC COMPLEMENTATION TEST; INTERFERONS; MICE; MICE, KNOCKOUT; PROTO-ONCOGENE PROTEINS C-BCL-2; RNA, DOUBLE-STRANDED; VESICULOVIRUS;

ENCEPHALOMYOCARDITIS VIRUS; VESICULAR STOMATITIS VIRUS;

EID: 80051917504     PISSN: 00426822     EISSN: 10960341     Source Type: Journal    
DOI: 10.1016/j.virol.2011.06.010     Document Type: Article

References (69)

1. Ackler S., Mitten M.J., Foster K., Oleksijew A., Refici M., Tahir S.K., Xiao Y., Tse C., Frost D.J., Fesik S.W., Rosenberg S.H., Elmore S.W., Shoemaker A.R. The Bcl-2 inhibitor ABT-263 enhances the response of multiple chemotherapeutic regimens in hematologic tumors in vivo. Cancer Chemother. Pharmacol. 2010, 66:869-880.
2. Adams K.W., Cooper G.M. Rapid turnover of mcl-1 couples translation to cell survival and apoptosis. J. Biol. Chem. 2007, 282:6192-6200.
3. Adams J.M., Cory S. Bcl-2-regulated apoptosis: mechanism and therapeutic potential. Curr. Opin. Immunol. 2007, 19:488-496.
4. Bandyopadhyay S.K., Leonard G.T., Bandyopadhyay T., Stark G.R., Sen G.C. Transcriptional induction by double-stranded RNA is mediated by interferon-stimulated response elements without activation of interferon-stimulated gene factor 3. J. Biol. Chem. 1995, 270:19624-19629.
5. Barber G.N. Host defense, viruses, and apoptosis. Cell Death Differ. 2001, 8:113-126.
6. Barber G.N. VSV-tumor selective replication and protein translation. Oncogene 2005, 24:7710-7719.
7. Barry G., Fragkoudis R., Ferguson M.C., Lulla A., Merits A., Kohl A., Fazakerley J.K. Semliki forest virus-induced endoplasmic reticulum stress accelerates apoptotic death of mammalian cells. J. Virol. 2010, 84:7369-7377.
8. Boyce M., Bryant K.F., Jousse C., Long K., Harding H.P., Scheuner D., Kaufman R.J., Ma D., Coen D.M., Ron D. A selective inhibitor of eIF2α dephosphorylation protects cells from ER stress. Science 2005, 307:935-939.
9. Chattopadhyay S., Yamashita M., Zhang Y., Sen G.C. The IRF-3/Bax-mediated apoptotic pathway, activated by viral cytoplasmic RNA and DNA, inhibits virus replication. J. Virol. 2011, 85:3708-3716.
10. Chawla-Sarkar M., Lindner D.J., Liu Y.F., Williams B.R., Sen G.C., Silverman R.H., Borden E.C. Apoptosis and interferons: role of interferon-stimulated genes as mediators of apoptosis. Apoptosis 2003, 8:237-249.
11. Chen L., Willis S.N., Wei A., Smith B.J., Fletcher J.I., Hinds M.G., Colman P.M., Day C.L., Adams J.M., Huang D.C. Differential targeting of prosurvival Bcl-2 proteins by their BH3-only ligands allows complementary apoptotic function. Mol. Cell 2005, 17:393-403.
12. Chen S., Blank J.L., Peters T., Liu X.J., Rappoli D.M., Pickard M.D. Genome-wide siRNA screen for modulators of cell death induced by proteasome inhibitor bortezomib. Cancer Res. 2010, 70:4318-4326.
13. Collins S.E., Noyce R.S., Mossman K.L. Innate cellular response to virus particle entry requires IRF3 but not virus replication. J. Virol. 2004, 78:1706-1717.
14. Fennell D.A., Chacko A., Mutti L. BCL-2 family regulation by the 20S proteasome inhibitor bortezomib. Oncogene 2008, 27:1189-1197.
15. Fernandez Y., Verhaegen M., Miller T.P., Rush J.L., Steiner P., Opipari A.W., Lowe S.W., Soengas M.S. Differential regulation of noxa in normal melanocytes and melanoma cells by proteasome inhibition: therapeutic implications. Cancer Res. 2005, 65:6294-6304.
16. Fernandez Y., Miller T.P., Denoyelle C., Esteban J.A., Tang W.H., Bengston A.L., Soengas M.S. Chemical blockage of the proteasome inhibitory function of bortezomib: impact on tumor cell death. J. Biol. Chem. 2006, 281:1107-1118.
17. Fritsch R.M., Schneider G., Saur D., Scheibel M., Schmid R.M. Translational repression of MCL-1 couples stress-induced eIF2 alpha phosphorylation to mitochondrial apoptosis initiation. J. Biol. Chem. 2007, 282:22551-22562.
18. George C.X., Li Z., Okonski K.M., Toth A.M., Wang Y., Samuel C.E. Tipping the balance: antagonism of PKR kinase and ADAR1 deaminase functions by virus gene products. J. Interferon Cytokine Res. 2009, 29:477-487.
19. Gomez-Bougie P., Wuillème-Toumi S., Ménoret E., Trichet V., Robillard N., Philippe M., Bataille R., Amiot M. Noxa up-regulation and Mcl-1 cleavage are associated to apoptosis induction by bortezomib in multiple myeloma. Cancer Res. 2007, 67:5418-5424.
20. Goubau D., Romieu-Mourez R., Solis M., Hernandez E., Mesplède T., Lin R., Leaman D.W., Hiscott J. Transcriptional re-programming of primary macrophages reveals distinct apoptotic and anti-tumoral functions of IRF-3 and IRF-7. Eur. J. Immunol. 2009, 39:527-540.
21. Grivennikov S.I., Greten F.R., Karin M. Immunity, inflammation, and cancer. Cell 2010, 140:883-899.
22. Haller O., Staeheli P., Kochs G. Interferon-induced Mx proteins in antiviral host defense. Biochimie 2007, 89:812-818.
23. Harding H.P., Calfon M., Urano F., Novoa I., Ron D. Transcriptional and translational control in the mammalian unfolded protein response. Annu. Rev. Cell Dev. Biol. 2002, 18:575-599.
24. Hassan M., Alaoui A., Feyen O., Mirmohammadsadegh A., Essmann F., Tannapfel A., Gulbins E., Schulze-Osthoff K., Hengge U.R. The BH3-only member Noxa causes apoptosis in melanoma cells by multiple pathways. Oncogene 2008, 27:4557-4568.
25. He B. Viruses, endoplasmic reticulum stress, and interferon responses. Cell Death Differ. 2006, 13:393-403.
26. Iwasaki A., Medzhitov R. Toll-like receptor control of the adaptive immune responses. Nat. Immunol. 2004, 5:987-995.
27. Jiang C.C., Lucas K., Avery-Kiejda K.A., Wade M., deBock C., Thorne R.F., Allen J., Hersey P., Zhang X.D. Up-regulation of Mcl-1 is critical for survival of human melanoma cells upon endoplasmic reticulum stress. Cancer Res. 2008, 68:6708-6717.
28. Jüllig M., Zhang W.V., Ferreira A., Stott N.S. MG132 induced apoptosis is associated with p53-independent induction of pro-apoptotic Noxa and transcriptional activity of beta-catenin. Apoptosis 2006, 11:627-641.
29. Kaufman R.J. Orchestrating the unfolded protein response in health and disease. J. Clin. Invest. 2002, 110:1389-1398.
30. Kim J.Y., Ahn H.J., Ryu J.H., Suk K., Park J.H. BH3-only protein Noxa is a mediator of hypoxic cell death induced by hypoxia-inducible factor 1alpha. J. Exp. Med. 2004, 199:113-124.
31. Kim J.K., Guan J., Chang I., Chen X., Han D., Wang C.Y. PS-341 and histone deacetylase inhibitor synergistically induce apoptosis in head and neck squamous cell carcinoma cells. Mol. Cancer Ther. 2010, 9:1977-1984.
32. Kohlhuber F., Rogers N.C., Watling D., Feng J., Guschin D., Briscoe J., Witthuhn B.A., Kotenko S.V., Pestka S., Stark G.R., Ihle J.N., Kerr I.M. A JAK1/JAK2 chimera can sustain alpha and gamma interferon responses. Mol. Cell. Biol. 1997, 17:695-706.
33. Kuroda J., Yamamoto M., Nagoshi H., Kobayashi T., Sasaki N., Shimura Y. Targeting activating transcription factor 3 by galectin-9 induces apoptosis and overcomes various types of treatment resistance in chronic myelogenous leukemia. Mol. Cancer Res. 2010, 8:994-1001.
34. Lai E., Teodoro T., Volchuk A. Endoplasmic reticulum stress: signaling the unfolded protein response. Physiology 2006, 22:193-201.
35. Lallemand C., Blanchard B., Palmieri M., Lebon P., May E., Tovey M.G. Single-stranded RNA viruses inactivate the transcriptional activity of p53 but induce Noxa-dependent apoptosis via post-translational modifications of IRF-1, IRF-3 and CREB. Oncogene 2007, 26:328-338.
36. Leaman D.W., Rosebeck S., Borden E.C. Biological and clinical properties of type I interferons. Immunotherapy of Cancer 2006, Humana Press, USA. M.L. Disis (Ed.).
37. Lee A.-H., Iwakoshi N.N., Anderson K.C., Glimcher L.H. Proteasome inhibitors disrupt the unfolded protein response in myeloma cells. PNAS 2003, 100:9946-9951.
38. Li J., Lee B., Lee A.S. Endoplasmic reticulum stress-induced apoptosis: multiple pathways and activation of p53-up-regulated modulator of apoptosis (PUMA) and NOXA by p53. J. Biol. Chem. 2006, 281:7260-7270.
39. Medigeshi G.R., Lancaster A.M., Hirsch A.J., Briese T., Lipkin W.I., Defilippis V., Früh K., Mason P.W., Nikolich-Zugich J., Nelson J.A. West Nile virus infection activates the unfolded protein response, leading to CHOP induction and apoptosis. J. Virol. 2007, 81:10849-10860.
40. Muller M., Briscoe J., Laxton C., Guschin D., Ziemiecki A., Silvennoinen O., Harpur A.G., Barbieri G., Witthuhn B.A., Schindler C., Pellegrini S., Wilks A.F., Ihle J.N., Stark G.R., Kerr I.M. The protein tyrosine kinase JAK1 complements defects in interferon-alpha/beta and -gamma signal transduction. Nature 1993, 366:129-135.
41. Nikiforov M.A., Riblett M., Tang W.H., Gratchouck V., Zhuang D., Fernandez Y., Verhaegen M., Varambally S., Chinnaiyan A.M., Jakubowiak A.J., Soengas M.S. Tumor cell-selective regulation of Noxa b c-myc in response to proteasome inhibition. PNAS 2007, 104:19488-19493.
42. Oda E., Ohki R., Murasawa H., Nemoto J., Shibue T., Yamashita T., Tokino T., Taniguchi T., Tanaka N. Noxa, a BH3-only member of the Bcl-2 family and candidate mediator of p53-induced apoptosis. Science 2000, 288:1053-1058.
43. Pearce A.F., Lyles D.S. Vesicular stomatitis virus induces apoptosis primarily through Bak rather than Bax by inactivating Mcl-1 and Bcl-XL. J. Virol. 2009, 83:9102-9112.
44. Pérez-Galán P., Roué G., Villamor N., Montserrat E., Campo E., Colomer D. The proteasome inhibitor bortezomib induces apoptosis in mantle-cell lymphoma through generation of ROS and Noxa activation independent of p53 status. Blood 2006, 107:257-264.
45. Perfettini J.-L., Roumier T., Castedo M., Larochette N., Boya P., Raynal B., Lazar V., Ciccosanti F., Nardacci R., Penninger J., Piacentini M., Kroemer G. NF-kappaB and p53 are the dominant apoptosis-inducing transcription factors elicited by the HIV-1 envelope. J. Exp. Med. 2004, 199:629-640.
46. Ploner C., Kofler R., Villunger A. Noxa: at the tip of the balance between life and death. Oncogene 2009, 27:S84-S92.
47. Puthalakath H., O'Reilly L.A., Gunn P., Lee L., Kelly P.N., Huntington N.D., Hughes P.D., Michalak E.M., McKimm-Breschkin J., Motoyama N., Gotoh T., Akira S., Bouillet P., Strasser A. ER stress triggers apoptosis by activating BH3-only protein Bim. Cell 2007, 129:1337-1349.
48. Ri M., Iida S., Ishida T., Ito A., Yano H., Inagaki A. Bortezomib-induced apoptosis in mature T-cell lymphoma cells partially depends on upregulation of Noxa and functional repression of Mcl-1. Cancer Sci. 2009, 100:341-348.
49. Ri M., Iida S., Nakashima T., Miyazaki H., Mori F., Ito A., Inagaki A., Kusumoto S., Ishida T., Komatsu H., Shiotsu Y., Ueda R. Bortezomib-resistant myeloma cell lines: a role for mutated PSMB5 in preventing the accumulation of unfolded proteins and fatal ER stress. Leukemia 2010, 24:1506-1512.
50. Sato M., Suemori H., Hata N., Asagiri M., Ogasawara K., Nakao K., Nakaya T., Katsuki M., Noguchi S., Tanaka N., Taniguchi T. Distinct and essential roles of transcription factors IRF-3 and IRF-7 in response to viruses for IFN-alpha/beta gene induction. Immunity 2000, 13:539-548.
51. Seo Y.W., Shin J.N., Ko K.H., Cha J.H., Park J.Y., Lee B.R., Yun C.W., Kim Y.M., Seol D.W., Kim D.W., Yin X.M., Kim T.H. The molecular mechanism of Noxa-induced mitochondrial dysfunction in p53-mediated cell death. J. Biol. Chem. 2003, 278:48292-48299.
52. Shibue T., Takeda K., Oda E., Tanaka H., Murasawa H., Takaoka A., Morishita Y., Akira S., Taniguchi T., Tanaka N. Integral role of Noxa in p53-mediate apoptotic response. Genes Dev. 2003, 17:2233-2238.
53. Silverman R.H. Viral encounters with 2',5'-oligoadenylate synthetase and RNase L during the interferon antiviral response. J. Virol. 2007, 81:12720-12729.
54. Stark G.R., Kerr I.M., Williams B.R., Silverman R.H., Schreiber R.D. How cells respond to interferons. Annu. Rev. Biochem. 1998, 67:227-264.
55. Sun Y., Leaman D.W. Involvement of Noxa in cellular apoptotic responses to interferons, double-stranded RNA, and virus infection. J. Biol. Chem. 2005, 280:15561-15568.
56. Szegezdi E., Logue S.E., Gorman A.M., Samali A. Mediators of endoplasmic reticulum stress-induced apoptosis. EMBO Rep. 2006, 7:880-885.
57. Takeuchi O., Akira S. Innate immunity to virus infection. Immunol. Rev. 2009, 227:75-86.
58. Traenckner E.B., Wilk S., Baeuerle P.A. A proteasome inhibitor prevents activation of NF-kappa B and stabilizes a newly phosphorylated form of IkappaB-alpha that is still bound to NF-kappa B. EMBO J. 1994, 13:5433-5441.
59. Umareddy I., Pluquet O., Wang Q.Y., Vasudevan S.G., Chevet E., Gu F. Dengue virus serotype infection specifies the activation of the unfolded protein response. Virology J. 2007, 4:91.
60. Villunger A., Michalak E.M., Coultas L., Müllauer F., Böck G., Ausserlechner M.J., Adams J.M., Strasser A. p53- and drug-induced apoptotic responses mediated by BH3-only proteins puma and noxa. Science 2003, 302:1036-1038.
61. Wang Q., Mora-Jensen H., Weniger M.A., Pérez-Galán P., Wolford C., Hai T., Ron D., Chen W., Trenkle W., Wiestner A., Ye Y. ERAD inhibitors integrate ER stress with an epigenetic mechanism to activate BH3-only protein Noxa in cancer cells. PNAS 2009, 106:2200-2205.
62. Weber A., Kirejczyk Z., Potthoff S., Ploner C., Häcker G. Endogenous Noxa determines the strong proapoptotic synergism of the BH3-mimetic ABT-737 with chemotherapeutic agents in human melanoma cells. Transl. Oncol. 2009, 2:73-83.
63. Wei M.C., Zong W.X., Cheng E.H., Lindsten T., Panoutsakopoulou V., Ross A.J., Roth K.A., MacGregor G.R., Thompson C.B., Korsmeyer S.J. Proapoptotic Bax and Bak: a requisite gateway to mitochondrial dysfunction and death. Science 2001, 292:727-730.
64. Willis S.N., Chen L., Dewson G., Wei A., Naik E., Fletcher J.I., Adams J.M., Huang D.C. Proapoptotic Bak is sequestered by Mcl-1 and Bcl-XL, but not Bcl-2, until displaced by BH3-only proteins. Genes Dev. 2005, 19:1294-1305.
65. Wiseman R.L., Balch W.E. A new pharmacology-drugging stresses folding pathways. Trends Mol. Med. 2005, 11:347-350.
66. Yakovlev A.G., Di Giovanni S., Wang G., Liu W., Stoica B., Faden A.I. Bok and Noxa are essential mediators of p53-dependent apoptosis. J. Biol. Chem. 2004, 279:28367-28374.
67. Yu C.Y., Hsu Y.W., Liao C.L., Lin Y.L. Flavivirus infection activates the XBP1 pathway of the unfolded protein response to cope with endoplasmic reticulum stress. J. Virol. 2006, 80:11868-11880.
68. Yu C.Y., Chiang R.L., Chang T.H., Liao C.L., Lin Y.L. The interferon stimulator mitochondrial antiviral signaling protein facilitates cell death by disrupting the mitochondrial membrane potential and by activating caspases. J. Virol. 2010, 84:2421-2431.
69. Zall H., Weber A., Besch R., Zantl N., Häcker G. Chemotherapeutic drugs sensitize human renal cell carcinoma cells to ABT-737 by a mechanism involving the Noxa-dependent inactivation of Mcl-1 or A1. Mol. Cancer 2010, 9:164-175.